Access InVivo brings together experts and partners united by a shared commitment to advancing global health. We champion patient-focused, evidence-based approaches to R&D and commercialisation.
Who We Are
We’re a small, driven team collaborating with some of the industry’s top experts and partners.
-
Mel Walker
CEO & FOUNDER
-
Helen Landels
HEAD OF OPERATIONS
-
Jennie Redstall
HEAD OF COMMUNICATIONS
-
Catherine Bacon
CEO, FINGERPOST CONSULTING
Mel Walker
CEO & Founder
Mel has over 20 years of experience in the pharmaceutical industry, and before founding Access InVivo, he led teams across market access, pricing, HEOR, evidence generation, portfolio strategy, business development and product launch. He has extensive R&D experience and is skilled at integrating commercial and access requirements into drug development, including at the global R&D board level.
Mel helps companies to understand and meet payer requirements, having worked in a broad range of therapeutic areas and led numerous HTA engagements, including alongside regulatory scientific advice. Mel co-founded the ISPOR HTA Regulatory interactions Special Interest Group, led a pioneering European HTA assessment (a precursor to Joint Clinical Assessments), and has a PhD in Patient Reported Outcomes.
Helen Landels
Head of Operations
Helen leads operations at Access InVivo, ensuring high-quality delivery and pragmatic, prioritised support for clients. She brings a unique perspective to market access, shaped by her experience across the NHS, consultancy, and NICE.
As a clinical pharmacist prescriber, she gained first-hand insight into patient and clinician needs. Her consultancy work deepened her understanding of developer challenges, while at NICE she led scientific advice meetings, drawing solutions from developer challenges and HTA requirements. Helen applies a solutions-driven mindset to help companies navigate payer expectations and HTA processes with confidence.
Jennie Redstall
Head of Communications
Jennie is a people-focused communications specialist who has built her career working across multiple sectors including education, technology and life sciences. Prior to becoming a fractional communications leader, she worked for a life science venture builder.
As Head of Programme and Community, she worked closely with early-stage companies to develop compelling communication materials, while also running the startup programme to support founder development. She is a qualified proofreader, copy editor and change manager, with a passion for creating inclusive and accessible communications.
Catherine Bacon
CEO, FingerPost Consulting
FingerPost consulting is an Access InVivo global delivery partner, with a network of in-market access specialists across all major territories. Catherine is the Founder and CEO and has over 15 years' experience working in market access.
She has an MSc in Neuroscience and her experience has included working with a wide range of different life science companies, which inspired her to develop market access solutions that address the challenges faced by pharmaceutical companies with small portfolios.
Our Partners and Advisors
We collaborate with top-tier advisors who bring direct decision-making experience, ensuring our guidance is grounded in real-world market dynamics.
Our industry experts are skilled in balancing risk and benefit, prioritising actions, and integrating payer needs into strategic drug development to optimise market outcomes.
Our payer advisors go beyond challenging assumptions — they understand company context and tailor recommendations to your specific needs and constraints.
By involving senior advisors with decades of experience, we help translate expert insight into actionable strategy.